← Back to home
Comparison · Analytics

DoseFinding vs osmapiR

A side-by-side editorial comparison of DoseFinding and osmapiR — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs osmapiR: at a glance

FeatureDoseFindingosmapiR
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingopenstreetmap, api-client, r-language, geospatial
Last editorial update45m ago1h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is osmapiR?

osmapiR is the rare API client that tracks its server's wiki revision numbers in the changelog.

osmapiR wraps the full OpenStreetMap API from R — reading and writing map data, changesets, notes, GPX traces and user records — with OAuth2 where the endpoint requires it, pagination handled internally, and atomic calls vectorised. Recent releases have filled in the moderation and social surface: note subscription, user blocks, changeset discussion search. The newest release lets `bbox` arguments arrive as a character string, matrix, vector, an sf `bbox`, or a terra `SpatExtent`.

Read the full osmapiR trajectory →

DoseFinding vs osmapiR: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

O
osmapiR
ANALYTICS
0.0

osmapiR is the rare API client that tracks its server's wiki revision numbers in the changelog.

◆ Current state

osmapiR wraps the full OpenStreetMap API from R — reading and writing map data, changesets, notes, GPX traces and user records — with OAuth2 where the endpoint requires it, pagination handled internally, and atomic calls vectorised. Recent releases have filled in the moderation and social surface: note subscription, user blocks, changeset discussion search. The newest release lets `bbox` arguments arrive as a character string, matrix, vector, an sf `bbox`, or a terra `SpatExtent`.

◆ Where it's heading

Four consecutive releases open with the same line — documentation and code updated for server-side changes, cited by OSM wiki revision range. That is a maintainer treating an evolving remote API as a versioned contract and auditing against it each cycle, which is unusual discipline and the main reason to trust this client over a hand-rolled wrapper. The second thread is fitting into R's spatial conventions rather than exposing OSM's, visible in the bbox coercion work and the httr2 upgrades landing with upstream help.

◆ Prediction

The pattern is stable enough to call: another release synchronised to the next OSM wiki revision range, adding whatever endpoints appeared and adjusting whatever changed shape.

Alternatives to DoseFinding and osmapiR

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or osmapiR.

See all DoseFinding alternatives → · See all osmapiR alternatives →

Recent activity from DoseFinding and osmapiR

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5mo agoosmapiRbbox arguments accept sf and terra objects
  2. 0y agoosmapiRNote search defaults to creation order; JSON for GPX metadata
  3. 1y agoDoseFindingConditional and predictive power for interim analyses
  4. 1y agoosmapiRNote subscriptions and user block endpoints added
  5. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  6. 1y agoosmapiRChangeset queries gain from and to parameters
  7. 1y agoosmapiRJOSS citation added; single-tag conversion fixed
  8. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  9. 2y agoosmapiRComplete OSM API coverage arrives in one release
  10. 2y agoDoseFindingCompliance update for R-devel
  11. 3y agoDoseFindingpowMCTBinCount bug fix

Frequently asked questions

What is the difference between DoseFinding and osmapiR?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and osmapiR are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than osmapiR?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and osmapiR are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to osmapiR?

Top osmapiR alternatives in Analytics are ranked by recent ship velocity. Browse the "osmapiR alternatives" section above for the current picks, or visit /alternatives/osmapir for the full list with editorial commentary on each.